Technological watch

Final issue of ECHA Newsletter published


In this September issue you can read an interview with Kestutis Sadauskas from the European Commission to learn about the aims of the EU’s Chemicals Strategy for Sustainability and how it will support companies to produce more sustainable chemicals.

Helsinki, 29 September 2020 – We look back to the spring when the EU Member States, supported by the European Commission and ECHA, took decisive action to speed up the supply of disinfectants to tackle the COVID-19 pandemic with the help of the ‘public health danger’ provision of the Biocidal Products Regulation.

In addition, we explain how the Commission is clarifying the meaning of ‘without undue delay’ related to registration updates in an upcoming implementing regulation and tell you how the practical solutions included in the amendment of Annex VIII to CLP will help companies comply with the harmonised requirements for poison centre notifications.

You can also read how enforcement and customs authorities have collaborated in a recent project to check if imported products contained certain restricted substances or met the requirements for classification, labelling and packaging. We also take a closer look at both REACH restriction and authorisation – explaining how the authorisation system has been used to control the use of substances of very high concern for more than a decade and how REACH restriction can supplement authorisation by also covering imported articles.

With this September issue, we say goodbye to the ECHA Newsletter. We have started to prepare for a new way of producing articles to make sure that you receive them in a more timely manner and so they are even more integrated into our news production. We expect to publish the first of our new articles in early 2021. You will find the articles as part of our news packages, linked to ECHA Weekly and shared through our social media channels.

Further information

Publication date: 29/09/2020



This project has received funding from the Bio Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme under grant agreement No 837761.